These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study. Dietmann AS; Kruse N; Stork L; Gloth M; Brück W; Metz I J Neurol; 2023 Mar; 270(3):1416-1429. PubMed ID: 36372867 [TBL] [Abstract][Full Text] [Related]
10. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis. Maggi P; Kuhle J; Schädelin S; van der Meer F; Weigel M; Galbusera R; Mathias A; Lu PJ; Rahmanzadeh R; Benkert P; La Rosa F; Bach Cuadra M; Sati P; Théaudin M; Pot C; van Pesch V; Leppert D; Stadelmann C; Kappos L; Du Pasquier R; Reich DS; Absinta M; Granziera C Neurology; 2021 Aug; 97(6):e543-e553. PubMed ID: 34088875 [TBL] [Abstract][Full Text] [Related]
11. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis. Fox RJ; Cree BAC; de Sèze J; Gold R; Hartung HP; Jeffery D; Kappos L; Montalban X; Weinstock-Guttman B; Singh CM; Altincatal A; Belviso N; Avila RL; Ho PR; Su R; Engle R; Sangurdekar D; de Moor C; Fisher E; Kieseier BC; Rudick RA Neurology; 2024 May; 102(9):e209357. PubMed ID: 38648580 [TBL] [Abstract][Full Text] [Related]
12. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628 [TBL] [Abstract][Full Text] [Related]
13. Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring. Calabresi PA; Arnold DL; Sangurdekar D; Singh CM; Altincatal A; de Moor C; Engle B; Goyal J; Deykin A; Szak S; Kieseier BC; Rudick RA; Plavina T Mult Scler; 2021 Sep; 27(10):1497-1505. PubMed ID: 33307998 [TBL] [Abstract][Full Text] [Related]
14. Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort. Steffen F; Uphaus T; Ripfel N; Fleischer V; Schraad M; Gonzalez-Escamilla G; Engel S; Groppa S; Zipp F; Bittner S Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411080 [TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis. Fujimori J; Nakashima I J Neurol Sci; 2021 Aug; 427():117528. PubMed ID: 34098375 [TBL] [Abstract][Full Text] [Related]
16. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Rosso M; Gonzalez CT; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T Ann Clin Transl Neurol; 2020 Jun; 7(6):945-955. PubMed ID: 32452160 [TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis. Srpova B; Uher T; Hrnciarova T; Barro C; Andelova M; Michalak Z; Vaneckova M; Krasensky J; Noskova L; Havrdova EK; Kuhle J; Horakova D Mult Scler; 2021 Jan; 27(1):52-60. PubMed ID: 31961243 [TBL] [Abstract][Full Text] [Related]
18. Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode. Plavina T; Singh CM; Sangurdekar D; de Moor C; Engle B; Gafson A; Goyal J; Fisher E; Szak S; Kinkel RP; Sandrock AW; Su R; Kieseier BC; Rudick RA JAMA Netw Open; 2020 Nov; 3(11):e2016278. PubMed ID: 33151313 [TBL] [Abstract][Full Text] [Related]
19. Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome. Fabis-Pedrini MJ; Kuhle J; Roberts KMA; Trend S; Jones AP; Maceski A; Carroll WM; Lucas RM; Mastaglia FL; Hart PH; Kermode AG Brain Behav; 2022 Feb; 12(2):e2494. PubMed ID: 35084124 [TBL] [Abstract][Full Text] [Related]
20. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study. Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]